Scopus BioPharma Announces Appointment of Additional Directors
Press release content from PR Newswire. The AP news staff was not involved in its creation. Scopus BioPharma Announces Appointment of Additional Directors December 29, 2020 GMT (PRNewsfoto/Scopus BioPharma Inc.) NEW YORK, Dec. 29, 2020 /PRNewswire/ -- Scopus BioPharma Inc. (Nasdaq: SCPS) today announced the appointment of additional members to its Board of Directors. Scopus is a biopharmaceutical company whose lead drug candidate is a novel, targeted immuno-oncology gene therapy for the treatment of multiple cancers. Joshua R. Lamstein, Chairman of Scopus BioPharma, stated, “We are delighte...
Source: apnews.com